[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487014":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":10,"centralContacts":23,"locations":29,"responsibleParty":45,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":10,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"RenJi Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"early breast cancer",null,"no requirements for therapy",[13],"Drug: pre-operative therapy",{"label":15,"type":10,"description":11,"interventionNames":16},"advanced breast cancer",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":10},"DRUG","pre-operative therapy","pre-operative therapy includes pre-operative chemotherapy, radiation, endocrine therapy, target therapy and other anti-tumor therapy",[15,9],[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Wenjin Yin","CONTACT","86(21)68385569","yinwenjin@renji.com",[30],{"facility":31,"status":32,"city":33,"state":10,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Renji Hospital, School of Medicine, Shanghai Jiaotong University","RECRUITING","Shanghai","200127","China","CN",{"type":38,"coordinates":39},"Point",[40,41],121.45806,31.22222,{"lat":41,"lon":40},[44],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},{"type":46,"investigatorFullName":25,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Deputy Chief of Breast Surgery Department","100487014","pre-operative-therapy-in-breast-cancer-100487014",false,"NCT05621564","Pre-operative Therapy in Breast Cancer","The Effect of Pre-operative Therapy on Response and Survival in Breast Cancer","Inclusion Criteria:\n\n* Female, Aged ≥18 years\n* Histologically confirmed primary breast cancer\n* Plan to receive pre-operative therapy\n* Adequate organ function\n\nExclusion Criteria:\n\n* History of neurological or psychological disease, including epilepsy or dementia\n* Not suitable to participate in this study judged by investigators","FEMALE","18 Years",{"count":58,"type":59},488,"ESTIMATED","OBSERVATIONAL","This is a prospective and retrospective study to evaluate the effect of pre-operative therapy on response and survival, and compare the difference in response and survival by pre-operative regimen or by patient's clinicopathological characteristic in early or advanced breast cancer.",[63],"Breast Cancer","2026-02-01",{"date":66,"type":67},"2026-02-03","ACTUAL",{"date":69,"type":67},"2022-11-01",{"date":71,"type":59},"2030-11",{"name":5,"class":6},1]